Biotech News

Opaleye Management Inc. buys $193k worth of Codexis stock, a move that sends ripples through the biotech and enzyme engineering sectors. This strategic investment, a significant bet on Codexis’s future, raises questions about Opaleye’s motivations and the potential impact on the biotech landscape. The investment, a testament to Opaleye’s keen …

Cargo Therapeutics CEO sells over $250k in company stock, a move that has sparked curiosity and raised eyebrows within the biotech industry. This significant transaction, involving a substantial sum of the CEO’s personal holdings, begs the question: what does this tell us about the company’s trajectory and the CEO’s confidence …